Oral Activated Charcoal Prevents Experimental Cerebral Malaria in Mice and in a Randomized Controlled Clinical Trial in Man Did Not Interfere with the Pharmacokinetics of Parenteral Artesunate

BACKGROUND: Safe, cheap and effective adjunct therapies preventing the development of, or reducing the mortality from, severe malaria could have considerable and rapid public health impact. Oral activated charcoal (oAC) is a safe and well tolerated treatment for acute poisoning, more recently shown...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, J. Brian, Okomo, Uduak, Alexander, Neal D., Aziz, Naveed, Owens, Benjamin M. J., Kaur, Harparkash, Jasseh, Momodou, Muangnoicharoen, Sant, Sumariwalla, Percy F., Warhurst, David C., Ward, Stephen A., Conway, David J., Ulloa, Luis, Tracey, Kevin J., Foxwell, Brian M. J., Kaye, Paul M., Walther, Michael
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855344/
https://www.ncbi.nlm.nih.gov/pubmed/20419161
http://dx.doi.org/10.1371/journal.pone.0009867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855344/
https://www.ncbi.nlm.nih.gov/pubmed/20419161
http://dx.doi.org/10.1371/journal.pone.0009867

Ejemplares similares